Key takeaways
- • Severity: No clinically significant interaction known.
- • Wegovy (weight management (FDA-approved obesity)) and Dapagliflozin (Farxiga) (SGLT2 inhibitor (diabetes/CV)).
- • Clinical management: Routinely combined without interaction-driven adjustment.
- • Monitoring: Standard diabetes, renal, and volume monitoring.
Mechanism
Like other SGLT2 inhibitors, dapagliflozin works via urinary glucose excretion and does not share a pharmacokinetic or pharmacodynamic conflict with semaglutide. The combination is routinely used in type 2 diabetes for additive metabolic and cardiorenal benefits.
Clinical management
Routinely combined without interaction-driven adjustment.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Wegovy or Dapagliflozin (Farxiga).
Monitoring
Standard diabetes, renal, and volume monitoring.
When to call your doctor
- signs of dehydration
- symptoms suggestive of DKA (rare)
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed in current FDA label as an interaction.
Editorial confidence: 9/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Dapagliflozin (Farxiga) with Wegovy?
Dapagliflozin (Farxiga) and Wegovy have no clinically significant interaction documented. Standard prescribing applies. Always confirm with your prescriber, since individual medical history can change the calculation.
What's the mechanism of any Wegovy + Dapagliflozin (Farxiga) interaction?
Like other SGLT2 inhibitors, dapagliflozin works via urinary glucose excretion and does not share a pharmacokinetic or pharmacodynamic conflict with semaglutide. The combination is routinely used in type 2 diabetes for additive metabolic and cardiorenal benefits.
What should I monitor when on Wegovy + Dapagliflozin (Farxiga)?
Standard diabetes, renal, and volume monitoring.
When should I call my doctor?
Contact your prescriber if you notice any of: signs of dehydration; symptoms suggestive of DKA (rare).
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.